
Our friendly team is available to help Monday to Friday 9:00am – 5:00pm.
If you need urgent assistance, do not use this service. Call 111, or in an emergency call 999.
0 items in your cart

Fast, discreet delivery
Free delivery over £40
100% UK-based pharmacy
All doctors & pharmacists UK-based
Free advice & support
Clinical support free · Mon–Fri 9am–5pm
Rated 4.9 out of 5
12,000+ verified patient reviews
Why Patients Choose Access Doctor
10+
Years serving UK patients
2,000+
Verified patient reviews
1,000+
Licensed treatments
24/7
Consultation available
Ovestin Cream is a topical treatment used to alleviate symptoms of atrophic vaginitis, a condition characterised by vaginal dryness and irritation commonly experienced by postmenopausal women due to lower oestrogen levels. The cream's active ingredient is estriol, a form of oestrogen, which supplements the body's natural oestrogen levels. This helps rejuvenate and maintain healthy vaginal tissue, relieving symptoms of vaginal atrophy.
Strength
Pack size
Order before 3pm — same-day dispatch (MON - FRI)
~5 min consultation
Secure & confidential · Reviewed by a UK prescriber
No subscription required · Free repeat prescriptions · Cancel anytime
Ovestin Cream is a topical treatment used to alleviate symptoms of atrophic vaginitis, a condition characterised by vaginal dryness and irritation commonly experienced by postmenopausal women due to lower oestrogen levels. The cream's active ingredient is estriol, a form of oestrogen, which supplements the body's natural oestrogen levels. This helps rejuvenate and maintain healthy vaginal tissue, relieving symptoms of vaginal atrophy.
Ovestin is a low-dose vaginal cream containing oestriol, a weaker form of oestrogen. It treats symptoms of vaginal and urinary atrophy associated with the menopause — collectively known as genitourinary syndrome of menopause (GSM). That includes dryness, soreness, itching, painful sex, urinary urgency, and recurrent urinary tract infections caused by thinning of the vaginal and bladder tissues.
Systemic HRT delivers enough oestrogen to circulate through the whole body and treat symptoms like hot flushes and mood changes. Ovestin is a local treatment: the oestriol acts on the vaginal and lower urinary tract tissues directly, with very little reaching the bloodstream. This means it doesn't usually help with flushes or night sweats, but the systemic risks normally discussed with HRT are also much lower.
The standard induction regimen is one applicator-full (around 0.5 mg oestriol) inserted into the vagina each evening for two to three weeks. After that, the dose is usually reduced to a maintenance level of one application twice a week. Bedtime is recommended because lying down for several hours improves contact with the tissue and reduces leakage.
Generally no. Because the dose is low and largely local, vaginal oestriol does not usually require additional progestogen for endometrial protection in most women. However, anyone using local oestrogen alongside a separate systemic HRT, or with unexplained bleeding, should always be reviewed by their clinician.
Many women feel some improvement in dryness and comfort within the first two to three weeks, during the daily induction phase. Full benefit — including reduced soreness during sex and fewer urinary symptoms — typically takes around three months of consistent use. Stopping treatment usually means symptoms gradually return, because the underlying tissue change is ongoing.
Yes. Most clinicians suggest avoiding intercourse on the night you've just applied a dose, both because the cream can transfer onto a partner and because the local tissue is still absorbing the hormone. On non-application nights, sex is fine, and many women find painful sex eases significantly within a few weeks.
If your partner is exposed to fresh cream, a very small amount of oestriol may transfer onto their skin or, with a male partner, onto the penis. The amount is small, but to minimise transfer it's worth applying the cream on nights when sex isn't planned, or making sure several hours have passed before intercourse.
Yes, in most cases. Vaginal atrophy is a chronic condition that returns when treatment stops, so long-term maintenance use is normal. Annual reviews with your GP or prescriber are sensible to check that symptoms remain controlled, that there's no unexplained bleeding, and that the dose is still appropriate.
This is a nuanced area. Many women with a history of breast cancer are able to use vaginal oestriol after a careful conversation with their oncology team, particularly when non-hormonal moisturisers and lubricants haven't given enough relief. The decision depends on tumour type, current treatments (especially aromatase inhibitors), and individual risk, so it should always be made jointly with an oncologist or specialist menopause clinician.
Most users tolerate it well. Mild local irritation, itching, or a slight increase in discharge are the most commonly reported effects, particularly in the first couple of weeks. Any new vaginal bleeding while using Ovestin should be reported to a clinician, as it needs to be assessed rather than assumed to be from the cream.
Yes. It's very common to use Ovestin or another local vaginal oestrogen alongside systemic HRT (patches, gel, spray, or tablets) when vaginal symptoms persist despite adequate systemic treatment. Local oestrogen targets tissues that systemic HRT doesn't always reach in sufficient amounts.
A missed dose during the maintenance phase isn't a concern — apply the next one as scheduled. During the initial daily phase, apply as soon as you remember, unless it's nearly time for the next dose, in which case skip the missed one. Never double up.
No reviews yet. Be the first to write one.
Helpful articles and clinical guides related to this treatment category.
Free consultation
Online review by a UK prescriber
Next-day delivery
Order before 3pm where offered
Discreet packaging
Plain outer packaging